OPRX Stock - OptimizeRx Corporation
Unlock GoAI Insights for OPRX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $92.13M | $71.52M | $62.45M | $61.29M | $43.31M |
| Gross Profit | $59.38M | $42.90M | $38.97M | $35.64M | $24.11M |
| Gross Margin | 64.5% | 60.0% | 62.4% | 58.1% | 55.7% |
| Operating Income | $-13,706,000 | $-26,402,000 | $-12,290,738 | $361,100 | $-2,135,319 |
| Net Income | $-20,110,000 | $-17,566,000 | $-11,438,440 | $378,079 | $-2,207,127 |
| Net Margin | -21.8% | -24.6% | -18.3% | 0.6% | -5.1% |
| EPS | $-1.10 | $-1.03 | $-0.64 | $0.02 | $-0.15 |
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
Visit WebsiteEarnings History & Surprises
OPRXEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Mar 11, 2026 | $0.23 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.03 | $0.20 | +566.7% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.03 | $0.24 | +700.0% | ✓ BEAT |
Q2 2025 | May 12, 2025 | $-0.11 | $0.08 | +172.7% | ✓ BEAT |
Q1 2025 | Mar 12, 2025 | $0.25 | $0.30 | +20.0% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $0.06 | $0.12 | +100.0% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $-0.07 | $0.02 | +128.6% | ✓ BEAT |
Q2 2024 | Apr 16, 2024 | $-0.13 | $0.26 | +300.0% | ✓ BEAT |
Q1 2024 | Mar 28, 2024 | $0.32 | $0.26 | -18.8% | ✗ MISS |
Q4 2023 | Nov 6, 2023 | $0.03 | $0.09 | +260.0% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.01 | $-0.01 | -53.4% | ✗ MISS |
Q2 2023 | May 10, 2023 | $-0.08 | $-0.09 | -12.5% | ✗ MISS |
Q1 2023 | Mar 8, 2023 | $0.24 | $0.25 | +4.2% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $0.04 | $0.07 | +90.7% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $0.10 | $0.04 | -60.0% | ✗ MISS |
Q2 2022 | May 4, 2022 | $-0.01 | $-0.01 | -15.2% | ✗ MISS |
Q1 2022 | Feb 24, 2022 | $0.18 | $0.22 | +22.2% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $0.13 | $0.09 | -30.8% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $0.07 | $0.10 | +42.9% | ✓ BEAT |
Latest News
Frequently Asked Questions about OPRX
What is OPRX's current stock price?
What is the analyst price target for OPRX?
What sector is OptimizeRx Corporation in?
What is OPRX's market cap?
Does OPRX pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to OPRX for comparison